Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin Neoadjuvant Therapy for HNSCC
NCT01195922Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Aug 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in head and neck squamous cell carcinoma (HNSCC), sponsored by National Institute of Dental and Craniofacial Research. Started Aug 2010; status: completed.
02
Drugs
sirolimus
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01195922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195922.